The collaboration aims to leverage STL’s expertise in digital infrastructure and Gennet Lab’s innovative healthcare solutions to transform hospital management systems in India. The initiative will enable real-time data access, optimize hospital workflows, and enhance patient care through secure, data-driven platforms.
Read More
The Indian pharmaceutical sector is projected to log a revenue growth of 8-10per cent this fiscal year, following a 10per cent growth last year, according to a CRISIL study.
Read More_20240915165721_original_image_36.webp)
Lymphoma is among the 10 most common cancers prevalent in India, in fact, some believe it to be in the top 6, and DLBCL accounts for almost 60 per cent of these Lymphoma cases.
Read More
BW Healthcare World hosted the 3rd edition of the 40 Under 40 Awards, alongside the inaugural BW Pharma World Person of the Year 2024, on August 31st at The Imperial Hotel.
Read More (1)_20240910154321_original_image_24.webp)
The Tata Motors 'Aarogya' program is a comprehensive health initiative to improve the well-being of underserved communities across India.
Read More
Fortis Memorial Research Institute, Gurugram, has launched a new MR Linac machine, the first of its kind in North India and the second in India. This advanced technology combines MRI with radiation therapy, offering improved cancer treatment.
Read More_20240903174817_original_image_27.webp)
PresVu is the first eye drop in India specifically designed to reduce the dependency on reading glasses for people with presbyopia.
Read More_20240903195420_original_image_47.webp)
3rd Edition of BW Healthcare World 40Under40 Awards and inaugural edition of BW Pharma World Person of the Year 2024 held at New Delhi on 31st Aug at The Imperial Hotel.
Read More
BW HealthcareWorld Person of the Year award celebrates those who have made significant contributions to India's healthcare and pharmaceutical industries, leading the way with innovation, and a commitment to improving the well-being of millions.
Read More
The Government of India’s Amrit Kaal blueprint -Vision Pharma 2047 – which envisages India as ‘Vishwaguru’ (global leader) in innovation & research underscores the Government's commitment to nurture an innovation-driven ecosystem
Read More
